SCHEDULE 13G/A: BlackRock Amends Stake in Cardlytics, Reports 2.1% Passive Ownership
Beneficial Ownership Report
BlackRock, Inc. has filed an Amendment No. 6 to its Schedule 13G, disclosing a 2.1% passive beneficial ownership stake in Cardlytics, Inc. as of June 30, 2025.
Summary
- BlackRock, Inc. filed an Amendment No. 6 to Schedule 13G regarding its ownership in CARDLYTICS,INC.
- BlackRock beneficially owns 1,098,977 shares of Cardlytics Common Stock.
- This represents 2.1% of the class of securities.
- BlackRock holds sole voting power over 1,095,873 shares and sole dispositive power over 1,098,977 shares.
- The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Cardlytics.
Sentiment
Score: 5
Explanation: The document is a factual, routine disclosure of passive ownership by an institutional investor, containing no positive or negative operational or financial news about the issuer.
Future Outlook
NA
Management Comments
- To the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
Industry Context
This filing is a routine disclosure by a large institutional investor, BlackRock, Inc., detailing its passive ownership stake in Cardlytics, Inc. It reflects standard portfolio management activities rather than a strategic industry move or competitive action.
Stakeholder Impact
- This filing primarily impacts shareholders by providing transparency on a significant institutional holding. It indicates BlackRock's continued passive investment in Cardlytics, which may be viewed as a vote of confidence by some investors, though it does not imply active involvement in company operations or strategy.
Key Dates
| Date | Description |
|---|---|
| 2023-04-30 | Date of previous Power of Attorney revoked by the new one. |
| 2025-01-21 | Date of the new Power of Attorney for BlackRock, Inc. |
| 2025-06-30 | Date of event which requires filing of this statement (beneficial ownership calculation date). |
| 2025-07-16 | Date of filing/signature of the Schedule 13G Amendment No. 6. |
Keywords
Cardlytics, BlackRock, Schedule 13G, Common Stock, Beneficial Ownership, Passive Investment, Financial Filing, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.